The value potential of KemPharm’s LAT™/prodrug technology is realized through regulatory approval of our product.

Apadaz™ (benzhydrocodone and acetaminophen)

Apadaz™ is a combination of benzhydrocodone, a prodrug of the opioid agonist hydrocodone, and acetaminophen that was approved by the U.S. Food and Drug Administration (FDA) on February 23, 2018.

Click here to view the product label.